New infusion drug AION-301 aims to slow kidney disease progression
Disease control
Recruiting now
This study tests whether two infusions of AION-301 are safe and can reduce symptoms or slow the worsening of Stage 3 chronic kidney disease. About 36 adults will receive either AION-301 or a placebo, along with oral vitamins, and be followed for up to 24 months. The main goal is …
Phase: PHASE1, PHASE2 • Sponsor: AION Healthspan, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC